DE3856101T2 - Den DEO-P1-P2 Promotor enthaltende Expressionsplasmide und diese Plasmide enthaltende bakterielle Wirte - Google Patents

Den DEO-P1-P2 Promotor enthaltende Expressionsplasmide und diese Plasmide enthaltende bakterielle Wirte

Info

Publication number
DE3856101T2
DE3856101T2 DE3856101T DE3856101T DE3856101T2 DE 3856101 T2 DE3856101 T2 DE 3856101T2 DE 3856101 T DE3856101 T DE 3856101T DE 3856101 T DE3856101 T DE 3856101T DE 3856101 T2 DE3856101 T2 DE 3856101T2
Authority
DE
Germany
Prior art keywords
plasmids
promoter
deo
human
control
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3856101T
Other languages
English (en)
Other versions
DE3856101D1 (de
Inventor
Meir Fischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SAVIENT PHARMACEUTICALS, INC. (N.D.GES.D. STAATES
Original Assignee
Savient Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Savient Pharmaceuticals Inc filed Critical Savient Pharmaceuticals Inc
Publication of DE3856101D1 publication Critical patent/DE3856101D1/de
Application granted granted Critical
Publication of DE3856101T2 publication Critical patent/DE3856101T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormones [GH] (Somatotropin)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0065—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE3856101T 1987-08-14 1988-08-11 Den DEO-P1-P2 Promotor enthaltende Expressionsplasmide und diese Plasmide enthaltende bakterielle Wirte Expired - Lifetime DE3856101T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8615987A 1987-08-14 1987-08-14

Publications (2)

Publication Number Publication Date
DE3856101D1 DE3856101D1 (de) 1998-02-12
DE3856101T2 true DE3856101T2 (de) 1998-07-23

Family

ID=22196678

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3856101T Expired - Lifetime DE3856101T2 (de) 1987-08-14 1988-08-11 Den DEO-P1-P2 Promotor enthaltende Expressionsplasmide und diese Plasmide enthaltende bakterielle Wirte

Country Status (17)

Country Link
EP (1) EP0303972B1 (de)
JP (1) JP2752092B2 (de)
KR (1) KR970000594B1 (de)
AT (1) ATE161888T1 (de)
AU (1) AU607249B2 (de)
CA (1) CA1309043C (de)
DE (1) DE3856101T2 (de)
DK (1) DK175537B1 (de)
ES (1) ES2112240T3 (de)
FI (1) FI104429B (de)
GR (1) GR3026136T3 (de)
HU (1) HU213418B (de)
IL (1) IL87409A (de)
NO (1) NO302185B1 (de)
NZ (1) NZ225760A (de)
PT (1) PT88271B (de)
ZA (1) ZA885983B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0282899B1 (de) * 1987-03-14 1996-01-10 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Humane Mangan-Superoxiddismutase (hMn-SOD)
US5260204A (en) * 1987-03-14 1993-11-09 Boehringer Ingelheim International Gmbh Human manganese superoxide dismutase (hMn-SOD)
US5210180A (en) * 1989-10-27 1993-05-11 American Cyanamid Company Enhancement of porcine somatotropin activity
US6165465A (en) * 1990-05-15 2000-12-26 American Cyanamid Company Immunologic enhancement of the somatogenic effect of somatotropin with an antibody

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201116B (en) * 1982-09-16 1990-09-28 Benzon As Alfred Process for producing plasmids having uncontrolled replication conduct under given circumstances

Also Published As

Publication number Publication date
EP0303972A2 (de) 1989-02-22
NO883611D0 (no) 1988-08-12
AU2098288A (en) 1989-03-09
JPH01157391A (ja) 1989-06-20
PT88271A (pt) 1989-06-30
NO302185B1 (no) 1998-02-02
ES2112240T3 (es) 1998-04-01
FI883749A0 (fi) 1988-08-12
DE3856101D1 (de) 1998-02-12
KR890003953A (ko) 1989-04-19
KR970000594B1 (ko) 1997-01-14
PT88271B (pt) 1995-07-18
AU607249B2 (en) 1991-02-28
DK175537B1 (da) 2004-11-29
DK454988D0 (da) 1988-08-12
IL87409A0 (en) 1989-01-31
EP0303972B1 (de) 1998-01-07
IL87409A (en) 1998-03-10
NZ225760A (en) 1991-02-26
FI104429B (fi) 2000-01-31
FI883749A (fi) 1989-02-15
ZA885983B (en) 1989-05-30
HU213418B (en) 1997-06-30
DK454988A (da) 1989-02-15
GR3026136T3 (en) 1998-05-29
HUT48681A (en) 1989-06-28
CA1309043C (en) 1992-10-20
ATE161888T1 (de) 1998-01-15
NO883611L (no) 1989-02-15
JP2752092B2 (ja) 1998-05-18
EP0303972A3 (de) 1991-12-18

Similar Documents

Publication Publication Date Title
FI842842A0 (fi) Menetelmä naudan, sian tai ihmisen kasvuhormonin polypeptidianalogin valmistamiseksi
DE3687651T2 (de) Analoge des gewebespezifischen plasminogenaktivators.
NO863806D0 (no) Arab promotorer og fremgangsmaate for fremstilling av polypeptider inkludert cecropiner, ved mikrobiologiske teknikker.
ATE112801T1 (de) Menschliche lactoferrin-cdna-sequenz.
DK164940C (da) Polypeptid med human-gamma-interferonaktivitet, genteknologisk fremgangsmaade til fremstilling deraf, hybrid-plasmider indeholdende en dna-sekvens, der koder for peptidet, vaertsorganismer indeholdende hybridplasmiderne, samt laegemidler, som indeholder polypeptidet
ES2063113T3 (es) Polipeptidos de veneno de vibora y expresion genetica.
DE3856101D1 (de) Den DEO-P1-P2 Promotor enthaltende Expressionsplasmide und diese Plasmide enthaltende bakterielle Wirte
ATE161885T1 (de) Expression der bindenden untereinheit des choleratoxins mit hilfe von fremden promotoren und/oder leadersequenzen
DE68923496T2 (de) Verfahren zur Herstellung von motilinähnlichen Polypeptiden und seine Expression.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SAVIENT PHARMACEUTICALS, INC. (N.D.GES.D. STAATES